MedPath

Physician Self Disclosure of IUC Use

Not Applicable
Completed
Conditions
Contraception
Interventions
Behavioral: Usual contraceptive counseling
Behavioral: Physician self-disclosure of personal IUC use
Registration Number
NCT01994356
Lead Sponsor
University of Michigan
Brief Summary

As many as one-third of female healthcare providers use intrauterine contraception (IUC), but only about 8 percent of US women overall do. This begs the question: Might physician self-disclosure of personal IUC use increase IUC use among patients? However, the positive or negative impact of physician self disclosure on IUC uptake or patient satisfaction is generally unknown. The purpose of this study was to evaluate if physician self-disclosure of personal IUC use increases patient use of IUC or impacts patients' satisfaction with their clinical encounter.

Detailed Description

We performed a prospective randomized block design pilot trail of usual contraceptive counseling versus usual counseling plus physician self-disclosure of personal intrauterine contraceptive use.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
132
Inclusion Criteria
  • reproductive age
  • currently sexually active
  • scheduled for benign gynecology visit, annual exam, or family planning visit
Read More
Exclusion Criteria
  • seeking pregnancy within 1 year
  • currently using IUC
  • prior sterilization procedure
  • currently pregnant
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Usual contraceptive counselingUsual contraceptive counselingsubjects received usual contraceptive counseling
Physician self-disclosure of IUC usePhysician self-disclosure of personal IUC usesubjects received usual contraceptive counseling plus intervention which was Physician self-disclosure of personal IUC use during the counseling
Primary Outcome Measures
NameTimeMethod
Intrauterine contraceptive useimmediately following clinical encounter and at 2 months

All subjects were surveyed to determine use of intrauterine contraceptive immediately after their clinical visit where contraceptive counseling was received and at 2 months after their clinical encounter to assess intrauterine contraceptive use.

Secondary Outcome Measures
NameTimeMethod
Satisfaction with clinical encounterimmediately following clinical encounter and at 2 months

All subjects were surveyed to determine their with satisfaction with their overall clinical encounter immediately following their clinical encounter at at 2 months. Satisfaction was measured using a 5 point scale.

Trial Locations

Locations (1)

University of Michigan Medical Center

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath